<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82641</article-id><article-id pub-id-type="doi">10.7554/eLife.82641</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>A mechanism of uncompetitive inhibition of the serotonin transporter</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-290032"><name><surname>Bhat</surname><given-names>Shreyas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290033"><name><surname>El-Kasaby</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290034"><name><surname>Kasture</surname><given-names>Ameya</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289921"><name><surname>Boytsov</surname><given-names>Danila</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290035"><name><surname>Reichelt</surname><given-names>Julian B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28066"><name><surname>Hummel</surname><given-names>Thomas</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8108-9307</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290036"><name><surname>Sucic</surname><given-names>Sonja</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221237"><name><surname>Pifl</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-105233"><name><surname>Freissmuth</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-104665"><name><surname>Sandtner</surname><given-names>Walter</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3637-260X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Institute of Pharmacology</institution>, <institution>Medical University of Vienna</institution>, <addr-line><named-content content-type="city">Vienna</named-content></addr-line>, <country>Austria</country></aff><aff id="aff2"><institution content-type="dept">Department of Neurobiology</institution>, <institution>University of Vienna</institution>, <addr-line><named-content content-type="city">Vienna</named-content></addr-line>, <country>Austria</country></aff><aff id="aff3"><institution content-type="dept">Center for Brain Research</institution>, <institution>Medical University of Vienna</institution>, <addr-line><named-content content-type="city">Vienna</named-content></addr-line>, <country>Austria</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-5115"><name><surname>Swartz</surname><given-names>Kenton J</given-names></name><role>Reviewing editor</role><aff><institution>National Institute of Neurological Disorders and Stroke, National Institutes of Health</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>walter.sandtner@meduniwien.ac.at</email> (WS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>01</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e82641</elocation-id><history><date date-type="received"><day>11</day><month>08</month><year>2022</year></date><date date-type="accepted"><day>17</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Bhat et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Bhat et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82641-v1.pdf"/><abstract><p>The serotonin transporter (SERT/SLC6A4) is arguably the most extensively studied solute carrier (SLC). During its eponymous action - i.e., the retrieval of serotonin from the extracellular space - SERT undergoes a conformational cycle. Typical inhibitors (antidepressant drugs and cocaine), partial and full substrates (amphetamines and their derivatives) and atypical inhibitors (ibogaine analogues) bind preferentially to different states in this cycle. This results in competitive or non-competitive transport inhibition. Here, we explored the action of N-formyl-1,3-bis (3,4-methylenedioxyphenyl)-prop-2-yl-amine (ECSI#6) on SERT: inhibition of serotonin uptake by ECSI#6 was enhanced with increasing serotonin concentration. Conversely, the K<sub>M</sub> for serotonin was lowered by augmenting ECSI#6. ECSI#6 bound with low affinity to the outward-facing state of SERT but with increased affinity to a potassium-bound state. Electrophysiological recordings showed that ECSI#6 preferentially interacted with the inward-facing state. Kinetic modeling recapitulated the experimental data and verified that uncompetitive inhibition arose from preferential binding of ECSI#6 to the K<sup>+</sup>-bound, inward-facing conformation of SERT. This binding mode predicted a pharmacochaperoning action of ECSI#6, which was confirmed by examining its effect on the folding-deficient mutant SERT-PG<sup>601,602</sup>AA: preincubation of HEK293 cells with ECSI#6 restored export of SERT-PG<sup>601,602</sup>AA from the endoplasmic reticulum and substrate transport. Similarly, in transgenic flies, the administration of ECSI#6 promoted the delivery of SERT-PG<sup>601,602</sup>AA to the presynaptic specialization of serotonergic neurons. To the best of our knowledge, ECSI#6 is the first example of an uncompetitive SLC inhibitor. Pharmacochaperones endowed with the binding mode of ECSI#6 are attractive, because they can rescue misfolded transporters at concentrations, which cause modest transport inhibition.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002428</institution-id><institution>Austrian Science Fund</institution></institution-wrap></funding-source><award-id>P31813</award-id><principal-award-recipient><name><surname>Sandtner</surname><given-names>Walter</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002428</institution-id><institution>Austrian Science Fund</institution></institution-wrap></funding-source><award-id>P31255-B27</award-id><principal-award-recipient><name><surname>Sucic</surname><given-names>Sonja</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001821</institution-id><institution>Vienna Science and Technology Fund</institution></institution-wrap></funding-source><award-id>LSC17-026</award-id><principal-award-recipient><name><surname>Freissmuth</surname><given-names>Michael</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>We uploaded original data onto Dyrad.The generated DOI is: doi.org/10.5061/dryad.fqz612jvz.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Sandtner W</collab></person-group><year iso-8601-date="2022">2022</year><source>A mechanism of uncompetitive inhibition of the serotonin transporter</source><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.5061/dryad.fqz612jvz">https://dx.doi.org/10.5061/dryad.fqz612jvz</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.fqz612jvz</comment></element-citation></p></sec></sec></back></article>